718 related articles for article (PubMed ID: 27061322)
1. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Del Boccio P; Rossi C; di Ioia M; Cicalini I; Sacchetta P; Pieragostino D
Proteomics Clin Appl; 2016 Apr; 10(4):470-84. PubMed ID: 27061322
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics in multiple sclerosis.
Bhargava P; Calabresi PA
Mult Scler; 2016 Apr; 22(4):451-60. PubMed ID: 26754801
[TBL] [Abstract][Full Text] [Related]
3. Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application.
Zhan X; Long Y; Lu M
J Proteomics; 2018 Sep; 188():30-40. PubMed ID: 28851587
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in Transplantation--Proteomics and Metabolomics.
Christians U; Klawitter J; Klawitter J
Ther Drug Monit; 2016 Apr; 38 Suppl 1(Suppl 1):S70-4. PubMed ID: 26418702
[TBL] [Abstract][Full Text] [Related]
5. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
Pecak M; Korošec P; Kunej T
OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
[TBL] [Abstract][Full Text] [Related]
6. An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.
Pieragostino D; D'Alessandro M; di Ioia M; Rossi C; Zucchelli M; Urbani A; Di Ilio C; Lugaresi A; Sacchetta P; Del Boccio P
Mol Biosyst; 2015 Jun; 11(6):1563-72. PubMed ID: 25690641
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics and Personalized Medicine.
Koen N; Du Preez I; Loots du T
Adv Protein Chem Struct Biol; 2016; 102():53-78. PubMed ID: 26827602
[TBL] [Abstract][Full Text] [Related]
8. Omics Biomarkers in Ophthalmology.
Lauwen S; de Jong EK; Lefeber DJ; den Hollander Al
Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO88-BIO98. PubMed ID: 28525563
[TBL] [Abstract][Full Text] [Related]
9. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
Corona G; Rizzolio F; Giordano A; Toffoli G
J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics toward personalized medicine.
Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment.
Rispoli MG; Valentinuzzi S; De Luca G; Del Boccio P; Federici L; Di Ioia M; Digiovanni A; Grasso EA; Pozzilli V; Villani A; Chiarelli AM; Onofrj M; Wise RG; Pieragostino D; Tomassini V
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681773
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics: Applications and Promise in Mycobacterial Disease.
Mirsaeidi M; Banoei MM; Winston BW; Schraufnagel DE
Ann Am Thorac Soc; 2015 Sep; 12(9):1278-87. PubMed ID: 26196272
[TBL] [Abstract][Full Text] [Related]
13. Metabolome 2.0: quantitative genetics and network biology of metabolic phenotypes.
Dumas ME
Mol Biosyst; 2012 Oct; 8(10):2494-502. PubMed ID: 22868675
[TBL] [Abstract][Full Text] [Related]
14. Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.
Schena FP; Serino G; Sallustio F; Falchi M; Cox SN
Nephrol Dial Transplant; 2018 Dec; 33(12):2101-2112. PubMed ID: 29905852
[TBL] [Abstract][Full Text] [Related]
15. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
[TBL] [Abstract][Full Text] [Related]
16. Integrative methods for analyzing big data in precision medicine.
Gligorijević V; Malod-Dognin N; Pržulj N
Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
[TBL] [Abstract][Full Text] [Related]
17. Innovation in metabolomics to improve personalized healthcare.
Cacciatore S; Loda M
Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry based proteomics and metabolomics in personalized oncology.
Kowalczyk T; Ciborowski M; Kisluk J; Kretowski A; Barbas C
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165690. PubMed ID: 31962175
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic and Proteomic Techniques for Establishing Biomarkers and Improving Our Understanding of Pathophysiology in Diabetic Nephropathy.
Siwy J; Ahonen L; Magalhães P; Frantzi M; Rossing P
Methods Mol Biol; 2020; 2067():287-306. PubMed ID: 31701458
[TBL] [Abstract][Full Text] [Related]
20. Proteomics and Metabolomics for AKI Diagnosis.
Marx D; Metzger J; Pejchinovski M; Gil RB; Frantzi M; Latosinska A; Belczacka I; Heinzmann SS; Husi H; Zoidakis J; Klingele M; Herget-Rosenthal S
Semin Nephrol; 2018 Jan; 38(1):63-87. PubMed ID: 29291763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
